Drawing for SWECURE

USPTO serial 79161776

SWECURE

Reviewed by CopyMark Law Group

Reg. 4934502Status 404
Filing date
Status date
Registration date
Apr 12, 2016
Examiner
TURNER, JASON FITZGERALD
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SWECURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan M. Natland

Susan M. Natland Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Bacterial cultures for addition to food products; Chemical and biological immunoassay reagents, other than for medical use; Immunoassay diagnostic reagents, other than for medical use, specifically used for science and research; Bacterial substances, namely, preparations for scientific use; Scientific probiotic bacterial formulations, namely, preparations other than for medical use; Diagnostic kits comprised of specimen receptors and reagents for testing for selected bacteria for scientific purposes; Proteins in raw material form for use in science; Proteins for use in the manufacture of foodstuffs; Immunological monoclonal and polyclonal antibodies, other than for medical use, specifically for scientific research; immunological antiserum, other than for medical use, specifically used for scientific researchSECTION 71 - CANCELLED—
005Dietetic foods adapted for infants, namely, medicinal drinks; Dietetic foods adapted for infants, namely, food supplements; Dietetic foods adapted for infants, namely, liquid-based food and yogurts for medical purposes; Dietetic foods adapted for invalids, namely, medicinal drinks; Dietetic foods adapted for invalids, namely, food supplements; Dietetic foods adapted for invalids, namely, liquid-based food and yogurts for medical purposes; Dietetic foods adapted for medical purposes, namely, medicinal drinks; Dietetic foods adapted for medical purposes, namely, food supplements; Dietetic foods adapted for medical purposes, namely, liquid-based food and yogurts for medical purposes; Medicines for the treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, dental disease, periodontal disease, acute pain, chronic pain, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, Irritable Bowel Syndrome, acute and chronic diarrhea, obesity, asthma, cancer, autoimmune diseases, eczema and psoriasis for human purposes; Pharmaceutical preparations for treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, gastrointestinal conditions, dental disease, periodontal disease, acute pain, chronic pain, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, Irritable Bowel Syndrome, acute and chronic diarrhea, obesity, asthma, cancer, autoimmune diseases, eczema and psoriasis and natural remedies, namely, remedy preparations for treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, gastrointestinal conditions, dental disease, periodontal disease, acute pain, chronic pain, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, Irritable Bowel Syndrome, acute and chronic diarrhea, obesity, asthma, cancer, autoimmune diseases, eczema and psoriasis; Nutritional food additives for medical purposes in the nature of natural food extracts derived from intestinal bacteria for human consumption; Dietetic foods for use in clinical nutrition, namely, medicinal drinks; Dietetic foods for use in clinical nutrition, namely, food supplements; Dietetic foods for use in clinical nutrition, namely, liquid-based food and yogurts for medical purposes; Food for diabetics, namely, medicinal drinks; Food for diabetics, namely, food supplements; Food for diabetics, namely, liquid-based food and yogurts for medical purposes; Food for medically restricted diets, namely, medicinal drinks; Food for medically restricted diets, namely, food supplements; Food for medically restricted diets, namely, liquid-based food and yogurts for medical purposes; Dietary and nutritional supplements for dietetic purposes; dietary and nutritional supplements, namely, tablets, pills, capsules, and liquids for dietetic purposes; Allergy medications; Probiotic bacterial formulations for medical use; Probiotic composition nutritional bacterial formulations for medical use; Bacteriological preparations for medical use; Bacteriological culture mediums for diagnostic purposes; Media for bacteriological cultures; Immunotherapeutic pharmaceutical preparation agents for bacterial infections; Bacterial preparations for medical useSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 25, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Apr 25, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 13, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 24, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 24, 2023INPCINVALIDATION PROCESSED—
Jun 28, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 28, 2022C71TCANCELLED SECTION 71—
Apr 12, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 5, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 15, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 15, 2016FIMPFINAL DISPOSITION PROCESSED—
Jul 12, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 12, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 26, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 26, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2016GPNXNOTIFICATION PROCESSED BY IB—
Jan 6, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 6, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 6, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 16, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 16, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Dec 16, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 16, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 16, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 8, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 8, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 8, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 11, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 10, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 10, 2015RFNPREFUSAL PROCESSED BY IB—
Mar 23, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 23, 2015RFRRREFUSAL PROCESSED BY MPU—
Mar 22, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 21, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 16, 2015DOCKASSIGNED TO EXAMINER—
Mar 16, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 13, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Mar 12, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance